Richard Wolf | Head of I.C.S.R. Case Management and Evaluation Regions and Pv Systems
C.S.L. Behring Gmbh

Richard Wolf, Head of I.C.S.R. Case Management and Evaluation Regions and Pv Systems, C.S.L. Behring Gmbh

Rich Wolf, Senior Director, Regions & Pv Operations in the Global Clinical Safety and Pharmacovigilance group at CSL Behring, directs Case Management, Medical Evaluation, Pv Systems (Argus), Manufacturing Site Pv, and the Global Regions organization responsible for Pv in affiliates around the world. Rich joined CSLB in 2014 after 12 years with J&J serving a number of different roles across drug safety and pharmacovigilance.  He spent 5 years working across multiple industries as a consultant and manager with Accenture.  He holds a BA from University of Richmond, and MBA from Rutgers University, is Six Sigma certified Black Belt, PMP certified in project management, and was an Airborne Ranger qualified officer in the US Army. CSL Behring is a global leader in the plasma protein biotherapeutics industry.  They research, develop, manufacture and market biotherapies that are used to treat serious and rare conditions.

Appearances:



Drug Safety World Day 2 @ 14:20

PHARMACOVIGILANCE IN CHINA SHOWCASE Navigating PV in new lands- studies and discussions on the implementation of PV in China

  • Implementing a Pharmacovigilance Support Model following acquisition of a local Company in China
  • The evolution of PV regulations and processes under pharmaceutical industry reform in China
  • Approaches to Pharmacovigilance Support Models based on business- Local market vs Global market in China 

back to speakers